A team of researchers has announced combined stem cell-gene therapy that has corrected a defective gene in cells taken from patients with a disorder called Fanconi Anemia. The study was published on May 31, 2009 in the magazine Nature.
The team of researchers have collaborated from several institutions, including the Universitat Autònoma de Barcelona, and the Centre for Regenerative Medicine of Barcelona, CIEMAT in Madrid, and The Salk Institute for Bilogical Studies in La Jolla, Ca. Dr. Juan Carlos Izpisua Belmonte, a professor at the Centre for Regenerative Medicine of Barcelona comments, “We haven’t cured a human being, but we have cured a cell. In theory we could transplant it into a human and cure the disease.”